Hormone replacement therapy and the endometrium

The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients

1985 • 1,243 citations

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

1975 • 996 citations

Association of Exogenous Estrogen and Endometrial Carcinoma

1975 • 950 citations

Hormone replacement therapy and endometrial cancer risk: A meta-analysis

1995 • 944 citations

Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women

1996 • 568 citations

Estrogens and Endometrial Cancer in a Retirement Community

1976 • 565 citations

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

1999 • 471 citations

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

1997 • 450 citations

Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.

1989 • 413 citations

Endometrial Cancer and Estrogen Use

1979 • 392 citations

Effects of long-term estrogen replacement therapy

1979 • 377 citations

Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy—long-term follow-up of a Swedish cohort

1996 • 326 citations

Estrogen-Progestin Replacement Therapy and Endometrial Cancer

1997 • 314 citations

Endometrial Intraepithelial Neoplasia (EIN): Will It Bring Order to Chaos?

2000 • 285 citations

Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone

1994 • 281 citations

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1991 • 276 citations

Effects of long-term estrogen replacement therapy

1979 • 251 citations

Risk of Localized and Widespread Endometrial Cancer in Relation to Recent and Discontinued Use of Conjugated Estrogens

1985 • 230 citations

Precursors of Corpus Carcinoma Estrogens and Adenomatous Hyperplasia

1947 • 226 citations

The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia

1989 • 221 citations

Increasing Incidence of Endometrial Cancer in the United States

1976 • 210 citations

The Stein-Leventhal Syndrome: Analysis of 43 Cases with Special Reference to Association with Endometrial Carcinoma**Abridgment of thesis submitted by Dr. Jackson to the Faculty of the Graduate School of the University of Minnesota in partial fulfillment of the requirements for the degree of Master of Science in Obstetrics and Gynecology.

1957 • 200 citations

Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry

2000 • 193 citations

Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.

1994 • 189 citations

Endometrial disease after treatment with oestrogens and progestogens in the climacteric.

1980 • 182 citations

Pipelle endometrial sampling in patients with known endometrial carcinoma.

1991 • 180 citations

Use of HRT and the subsequent risk of cancer.

1999 • 169 citations

Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.

1993 • 153 citations

Endometrial morphology in asymptomatic postmenopausal women

1991 • 147 citations

The Role and Use of Progestogens

1990 • 146 citations

Compliance considerations with estrogen replacement: Withdrawal bleeding and other factors

1989 • 141 citations

A Simple Method for Determining the Optimal Dosage of Progestin in Postmenopausal Women Receiving Estrogens

1986 • 139 citations

Recent and Past Use of Conjugated Estrogens in Relation to Adenocarcinoma of the Endometrium

1980 • 137 citations

Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone

1994 • 134 citations

Endometrial Histology and Biochemistry in Climacteric Women during Oestrogen and Oestrogen/Progestogen Therapy

1979 • 131 citations

Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient

1990 • 121 citations

?

1995 • 120 citations

Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study

1989 • 117 citations

Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation

1981 • 113 citations

Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints

1982 • 104 citations

The endometrial response to sequential and continuous combined oestrogen‐progestogen replacement therapy

2000 • 97 citations

Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: influence of bleeding pattern and secretory changes

1993 • 96 citations

Estrogen replacement therapy and the risk of endometrial cancer: Remaining controversies

1990 • 92 citations

Risk of Endometrial Cancer in Relation to Use of Low-Dose, Unopposed Estrogens

1998 • 85 citations

Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestagen replacement therapy?

1994 • 85 citations

Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and postmenopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study)

1997 • 81 citations

A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium.

1989 • 74 citations

Adverse endometrial effects during long cycle hormone replacement therapy

1999 • 74 citations

Histological sampling of the endometrium—A comparison between formal curettage and the Pipelle sampler

1992 • 72 citations

EXOGENOUS ESTROGENS AND ENDOMETRIAL CANCER: A CASE-CONTROL STUDY AND ASSESSMENT OF POTENTIAL BIASES

1981 • 69 citations

Endometrial polyps during menopause, characterization and significance

1999 • 68 citations

17β-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy

1996 • 66 citations

A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment

1993 • 64 citations

Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints

1988 • 63 citations

Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women

1992 • 59 citations

Hysteroscopy and transvaginal sonography in menopausal women receiving hormone replacement therapy

1996 • 57 citations

Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology.

1999 • 57 citations

Continuous combined conjugated equine estrogen—progestogen therapy: Effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis

1992 • 55 citations

Outpatient pipelle endometrial biopsy in the investigation of postmenopausal bleeding

1994 • 53 citations

Women's opinion on withdrawal bleeding with hormone replacement therapy

1993 • 50 citations

CONTINUOUS TREATMENT WITH A COMBINATION OF ESTROGEN AND GESTAGEN—A WAY OF AVOIDING ENDOMETRIAL STIMULATION

1985 • 43 citations

Bleeding Pattern and Endometrial Changes During Continuous Combined Hormone Replacement Therapy

1998 • 43 citations

Oestrogen replacement treatment and the risk of endometrial cancer: an assessment of the role of covariates

1993 • 42 citations

Granulosatheca cell tumors and endometrial carcinoma; a study of their relationship and a survey of 80 cases.

1955 • 42 citations

Endometrial polyps during menopause, characterization and significance

1999 • 41 citations

Penetration into bone and tissues of clindamycin phosphate

1978 • 35 citations

Development of Endometrial Cancer in Women on Estrogen and Progestin Hormone Replacement Therapy

1994 • 34 citations

Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women

1996 • 32 citations

Endometrial status in post-menopausal women on long-term continuous combined hormone replacement therapy (Kliofem®) a comparative study of endometrial biopsy, outpatient hysteroscopy and transvaginal ultrasound

1997 • 30 citations

Continuous Low-Dose Combined Hormone Replacement Therapy and the Risk of Endometrial Cancer

1997 • 30 citations

95039031 Hormone replacement therapy and endometrial cancer risk: A meta-analysis

1995 • 28 citations

92016232 Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women

1992 • 26 citations

Endometrial responses to hormone replacement therapy: histological features compared with those of late luteal phase endometrium

1998 • 24 citations

The endometrial status of women on longterm continuous combined hormone replacement therapy

1991 • 23 citations

Cancer incidence and mortality in women receiving estrogen and estrogen‐progestin replacement therapy—long‐term follow‐up of a Swedish cohort

1996 • 21 citations

Biochemical studies on endometrium from postmenopausal women receiving hormone replacement therapy.

1978 • 18 citations

On menstrual bleeding with hormone replacement therapy

1994 • 14 citations

Can endometrial protection be inferred from the bleeding pattern on combined cyclical hormone replacement therapy

2000 • 11 citations

91257926 Endometrial morphology in asymptomatic postmenopausal women

1992 • 10 citations

Endometrial Cancer and Estrogen Use. Report of a Large Case Control Study

1979 • 9 citations

Bleeding Pattern and Endometrial Changes During Continuous Combined Hormone Replacement Therapy

1998 • 6 citations

Combined continuous hormone replacement therapy: A critical review

1995 • 4 citations

91230344 Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1992 • 4 citations

Accumulated knowledge of Kliogest safety aspects.

1996 • 3 citations

Estrogen replacement therapy and the risk of endometrial cancer: Remaining controversies

1990 • 2 citations

Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient

1991 • 2 citations

P144 Effects of continuous combined estrogen and progestogen replacement therapy on the uterine vasculatur tree of postmenopausal women

1996 • 1 citations

Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy

1995 • 1 citations

Deleted Work

1955 • 0 citations